These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23241112)
1. Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from COPD patients and healthy individuals. Golec M; Reichel C; Lemieszek M; Mackiewicz B; Buczkowski J; Sitkowska J; Skòrska C; Dutkiewicz J; Milanowski J; Ziesche R J Biol Regul Homeost Agents; 2012; 26(4):617-25. PubMed ID: 23241112 [TBL] [Abstract][Full Text] [Related]
2. Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from healthy individuals and sarcoidosis patients. Golec M; Reichel C; Lemieszek M; Buczkowski J; Mackiewicz B; Skórska C; Dutkiewicz J; Góra A; Ziesche R; Milanowski J J Biol Regul Homeost Agents; 2014; 28(1):73-9. PubMed ID: 24750793 [TBL] [Abstract][Full Text] [Related]
3. Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD. Golec M; Reichel C; Mackiewicz B; Skorska C; Curzytek K; Lemieszek M; Dutkiewicz J; Gora A; Ziesche R; Boltuc J; Sodolska K; Milanowski J; Spiewak R Ann Agric Environ Med; 2009; 16(2):289-97. PubMed ID: 20047264 [TBL] [Abstract][Full Text] [Related]
4. The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease. Jiang YY; Xiao W; Zhu MX; Yang ZH; Pan XJ; Zhang Y; Sun CC; Xing Y Respir Med; 2012 Dec; 106(12):1680-9. PubMed ID: 22981321 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease. Uysal P; Simsek G; Durmus S; Sozer V; Aksan H; Yurt S; Cuhadaroglu C; Kosar F; Gelisgen R; Uzun H Int J Chron Obstruct Pulmon Dis; 2019; 14():321-330. PubMed ID: 30774329 [TBL] [Abstract][Full Text] [Related]
6. Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. Chen CI; Schaller-Bals S; Paul KP; Wahn U; Bals R J Cyst Fibros; 2004 Mar; 3(1):45-50. PubMed ID: 15463886 [TBL] [Abstract][Full Text] [Related]
7. The human cathelicidin LL-37 enhances airway mucus production in chronic obstructive pulmonary disease. Zhang Y; Jiang Y; Sun C; Wang Q; Yang Z; Pan X; Zhu M; Xiao W Biochem Biophys Res Commun; 2014 Jan; 443(1):103-9. PubMed ID: 24291709 [TBL] [Abstract][Full Text] [Related]
8. LL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary disease. Sun C; Zhu M; Yang Z; Pan X; Zhang Y; Wang Q; Xiao W Lab Invest; 2014 Sep; 94(9):991-1002. PubMed ID: 24955895 [TBL] [Abstract][Full Text] [Related]
9. Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. Türkoğlu O; Emingil G; Kütükçüler N; Atilla G J Periodontol; 2009 Jun; 80(6):969-76. PubMed ID: 19485828 [TBL] [Abstract][Full Text] [Related]
10. Cathelicidin and human β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis. Cakir E; Torun E; Gedik AH; Umutoglu T; Aktas EC; Topuz U; Deniz G Int J Tuberc Lung Dis; 2014 Jun; 18(6):671-5. PubMed ID: 24903937 [TBL] [Abstract][Full Text] [Related]
11. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Golec M Ann Agric Environ Med; 2007; 14(1):1-4. PubMed ID: 17655171 [TBL] [Abstract][Full Text] [Related]
12. Endotoxin Exposure Increases LL-37 - but Not Calprotectin - in Healthy Human Airways. Smith ME; Stockfelt M; Tengvall S; Bergman P; Lindén A; Qvarfordt I J Innate Immun; 2017; 9(5):475-482. PubMed ID: 28605742 [TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease. Jiang Y; Xiao W; Zhang Y; Xing Y Respirology; 2010 Aug; 15(6):939-46. PubMed ID: 20624254 [TBL] [Abstract][Full Text] [Related]
14. Lung allograft donors with excessive alcohol use have increased levels of human antimicrobial peptide LL-37. Camargo Moreno M; Lewis JB; Kovacs EJ; Lowery EM Alcohol; 2019 Nov; 80():109-117. PubMed ID: 30419299 [TBL] [Abstract][Full Text] [Related]
15. Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin. Galván EM; Lasaro MA; Schifferli DM Infect Immun; 2008 Apr; 76(4):1456-64. PubMed ID: 18227173 [TBL] [Abstract][Full Text] [Related]
16. Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity. Perea L; Rodrigo-Troyano A; Cantó E; Domínguez-Álvarez M; Giner J; Sanchez-Reus F; Villar-García J; Quero S; García-Núñez M; Marín A; Monsó E; Faner R; Agustí A; Vidal S; Sibila O Respir Res; 2020 Jan; 21(1):21. PubMed ID: 31931795 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Hou M; Zhang N; Yang J; Meng X; Yang R; Li J; Sun T Cell Physiol Biochem; 2013; 32(3):614-23. PubMed ID: 24021961 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. Persson LJ; Aanerud M; Hardie JA; Miodini Nilsen R; Bakke PS; Eagan TM; Hiemstra PS Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298400 [TBL] [Abstract][Full Text] [Related]
19. Damage-Associated Molecular Patterns and Myeloid-Derived Suppressor Cells in Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease Patients. Brajer-Luftmann B; Nowicka A; Kaczmarek M; Wyrzykiewicz M; Yasar S; Piorunek T; Sikora J; Batura-Gabryel H J Immunol Res; 2019; 2019():9708769. PubMed ID: 31355298 [TBL] [Abstract][Full Text] [Related]
20. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Kilsgård O; Andersson P; Malmsten M; Nordin SL; Linge HM; Eliasson M; Sörenson E; Erjefält JS; Bylund J; Olin AI; Sørensen OE; Egesten A Am J Respir Cell Mol Biol; 2012 Feb; 46(2):240-8. PubMed ID: 21960546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]